Drug development continues amid Guinea Ebola outbreak

03/26/2014 | Bloomberg

Ebola virus

Scientists are closing in on effective treatments for Ebola, a deadly zoonotic virus that causes fever, vomiting, diarrhea and internal and external hemorrhaging and has shown up in a recent outbreak in Guinea. Several treatments show promise, including the flu drug favipiravir, cancer drugs Gleevec and Tasigna, and several antibody cocktails in development. Human trials of a new Ebola drug were begun in January by Tekmira Pharmaceuticals, which has Defense Department funding for the research.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA